Malik Fady Ibraham Insider Trades

Insider Trading History

Track insider trading activity for Malik Fady Ibraham. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $10.9M 153,902 shares
Last Trade
May 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$265k 3,500 shares
$75.69
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $3.39M 47,886 shares
Last Trade
May 19, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$268k 3,500 shares
$76.45
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $11.1M 157,402 shares
Last Trade
May 19, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$268k 3,500 shares
$76.45
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $3.63M 51,386 shares
Last Trade
May 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$270k 3,500 shares
$77.09
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $11.1M 157,402 shares
Last Trade
May 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$270k 3,500 shares
$77.09
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $10.9M 153,902 shares
Last Trade
May 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$271k 3,500 shares
$77.37
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $3.88M 54,886 shares
Last Trade
Apr 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$230k 3,500 shares
$65.80
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $11.1M 157,402 shares
Last Trade
Apr 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$230k 3,500 shares
$65.80
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $10.9M 153,902 shares
Last Trade
Apr 21, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$230k 3,500 shares
$65.69
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $4.13M 58,386 shares
Last Trade
Apr 07, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$295k 4,500 shares
$65.48
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $11.1M 157,402 shares
Last Trade
Apr 07, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$295k 4,500 shares
$65.48
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $10.9M 153,902 shares
Last Trade
Apr 07, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$293k 4,500 shares
$65.11
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $11.2M 158,299 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$748k 12,033 shares
$62.15
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $11.7M 165,935 shares
Last Trade
Mar 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.11M 68,498 shares
$60.06
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $9.8M 138,629 shares
Last Trade
Mar 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$177k 2,907 shares
$60.72
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $10M 141,536 shares
Last Trade
Dec 22, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$63.7k 1,016 shares
$62.72
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $10.1M 142,552 shares
Last Trade
Dec 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$262k 4,000 shares
$65.60
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $9.95M 140,752 shares
Last Trade
Dec 16, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$136k 2,200 shares
$62.02
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $9.8M 138,552 shares
Last Trade
Dec 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$135k 2,200 shares
$61.24
$70.71
Cytokinetics
Cytokinetics CYTK
EVP Research & Development
Holding Value $0 0 shares
Last Trade
Dec 16, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$136k 2,200 shares
$62.02
$70.71

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up